In vitro behavior and UV response of melanocytes derived from carriers of CDKN2A mutations and MC1R variants.


Journal

Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927

Informations de publication

Date de publication:
03 2019
Historique:
received: 04 06 2018
revised: 03 08 2018
accepted: 09 08 2018
pubmed: 18 8 2018
medline: 9 8 2019
entrez: 18 8 2018
Statut: ppublish

Résumé

Coinheritance of germline mutation in cyclin-dependent kinase inhibitor 2A (CDKN2A) and loss-of-function (LOF) melanocortin 1 receptor (MC1R) variants is clinically associated with exaggerated risk for melanoma. To understand the combined impact of these mutations, we established and tested primary human melanocyte cultures from different CDKN2A mutation carriers, expressing either wild-type MC1R or MC1RLOF variant(s). These cultures expressed the CDKN2A product p16 (INK4A) and functional MC1R. Except for 32ins24 mutant melanocytes, the remaining cultures showed no detectable aberrations in proliferation or capacity for replicative senescence. Additionally, the latter cultures responded normally to ultraviolet radiation (UV) by cell cycle arrest, JNK, p38, and p53 activation, hydrogen peroxide generation, and repair of DNA photoproducts. We propose that malignant transformation of melanocytes expressing CDKN2A mutation and MC1RLOF allele(s) requires acquisition of somatic mutations facilitated by MC1R genotype or aberrant microenvironment due to CDKN2A mutation in keratinocytes and fibroblasts.

Identifiants

pubmed: 30117292
doi: 10.1111/pcmr.12732
doi:

Substances chimiques

Cyclin-Dependent Kinase Inhibitor p15 0
Neoplasm Proteins 0
Receptor, Melanocortin, Type 1 0
Retinoblastoma Protein 0
beta-Galactosidase EC 3.2.1.23

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

259-268

Subventions

Organisme : NCI NIH HHS
ID : R21 CA183440
Pays : United States

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Barbara Hernando (B)

Department of Medicine, Jaume I University of Castellon, Castellon, Spain.

Viki B Swope (VB)

Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Steven Guard (S)

Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Renny J Starner (RJ)

Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Kevin Choi (K)

Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Ayesha Anwar (A)

Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Pamela Cassidy (P)

Department of Dermatology, Oregon Health and Sciences University, Portland, Oregon.

Sancy Leachman (S)

Department of Dermatology, Oregon Health and Sciences University, Portland, Oregon.

Ana Luisa Kadekaro (AL)

Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Dorothy C Bennett (DC)

Molecular & Clinical Sciences Research Institute, St George's, University of London, London, UK.

Zalfa A Abdel-Malek (ZA)

Department of Dermatology, University of Cincinnati, Cincinnati, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH